Phase 2 Study Shows Opdivo-Yervoy Highly Effective In Colon Cancer

1 year ago 125
A four-week course of the dual immunotherapy Opdivo-Yervoy prior to surgery is highly effective in treating a certain type (dMMR) of non-metastatic colorectal cancer.
Read Entire Article